 |
|
 |
Hospitals and Health Systems |
|
| |
- That continue to put significant pressures on cost management
and revenue recovery.
- That have concerns about patient safety driving investment
in clinical systems.
|
|
Employers and Health Insurance |
|
| |
- Where employer and government cost containment is driving
consumer driven product designs.
- Where cyclic pressures and newer products will reduce
growth in premium revenues and will drive greater need for
further administrative cost reductions.
- Where chronic disease consumes a significant majority
of healthcare spending.
- Where payers will seek better intelligence about their
covered populations in an effort to target programs for
chronic diseases.
|
|
Pharmaceutical and Life Sciences |
|
| |
- That face increased scrutiny on drug safety and quality
control.
- That see pressure to curb costs along the full value chain.
|
|
| |
